Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × High Grade Serous Carcinoma × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 592 Neoplasms 531 Prostatic Neoplasms 268 Carcinoma, Non-Small-Cell Lung 251 Colorectal Neoplasms 239 Lung Neoplasms 202 Melanoma 149 Multiple Myeloma 143 Neoplasm Metastasis 141 Pancreatic Neoplasms 134 Ovarian Neoplasms 125 Head and Neck Neoplasms 119 Leukemia, Myeloid, Acute 112 Colonic Neoplasms 111 Carcinoma, Hepatocellular 107 Brain Neoplasms 104 Squamous Cell Carcinoma of Head and Neck 103 Uterine Cervical Neoplasms 94 Stomach Neoplasms 94 Recurrence 93 Lymphoma 91 Glioblastoma 77 Urinary Bladder Neoplasms 75 Hematologic Neoplasms 73 Lymphoma, Follicular 72 Precursor Cell Lymphoblastic Leukemia-Lymphoma 69 Lymphoma, Non-Hodgkin 67 Motor Activity 64 Carcinoma, Renal Cell 64 Glioma 62

Interventions

olaparib 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03462342 2026-03-17

CAPRI

University of Pennsylvania

Phase 2 Completed

High Grade Serous Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡